Board

GF/B33/DP08

Approved by the Board on: 01 April 2015


Policy on Co-infections and Co-morbidities

  1. The Board acknowledges its approval of an interim measure for the financing of Hepatitis C virus treatment until the approval of a broader policy on co-infections and co-morbidities of HIV/AIDS, tuberculosis and malaria (GF/B32/DP07).
  2. Based on the recommendations of the Strategy, Investment and Impact Committee, the Board approves the framework for financing co-infections and co-morbidities of HIV/AIDS, tuberculosis and malaria, as set forth in GF/B33/11.
  3. Accordingly, the Board notes this decision point supersedes GF/B32/DP07.

  • Related Documents

    • GF/B33/11 - Policy on Co-Infections and Co-Morbidities
      download in English